DOI: 10.1128/CVI.00738-13
Article Information
PubMed
Published By
History
- Received November 19, 2013
- Returned for modification November 29, 2013
- Accepted December 6, 2013
- Published online January 29, 2014.
Copyright & Usage
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Editors and / or Reviewers
- D. L. Burns, Editor
Article Versions
- Accepted Manuscript version (December 18, 2013).
- You are viewing the most recent version of this article.
Author Information
- Katharina Richarda,
- Barbara J. Mannb,
- Lenea Stockerc,
- Eileen M. Barryd,
- Aiping Qinb,
- Leah E. Colea*,
- Matthew T. Hurleyc,
- Robert K. Ernste,
- Suzanne M. Michalekf,
- Daniel C. Steing,
- Philip DeShongc and
- Stefanie N. Vogela
- aDepartment of Microbiology and Immunology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland, USA
- bDepartment of Medicine, Division of Infectious Diseases and International Health, University of Virginia School of Medicine, Charlottesville, Virginia, USA
- cDepartment of Chemistry and Biochemistry, University of Maryland College Park, College Park, Maryland, USA
- dCenter for Vaccine Development, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland, USA
- eDepartment of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA
- fDepartment of Microbiology, University of Alabama Birmingham, Birmingham, Alabama, USA
- gDepartment of Cell Biology and Molecular Genetics, University of Maryland College Park, College Park, Maryland, USA
- Address correspondence to Stefanie N. Vogel, svogel{at}som.umaryland.edu.
↵* Present address: Leah E. Cole, Sanofi Pasteur Biologics Co., Cambridge, Massachusetts, USA.
Article usage
Novel Catanionic Surfactant Vesicle Vaccines Protect against Francisella tularensis LVS and Confer Significant Partial Protection against F. tularensis Schu S4 Strain
